Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bicalutamide (casodex) (1 trial)
goserelin (zoladex) (1 trial)
lovastatin (mevacor) (1 trial)
minocycline (minocin) (2 trials)
11c acetate (1 trial)
[3-3h]-glucose (1 trial)
fludeoxyglucose f-18 (1 trial)
glycerin (1 trial)
mirabegron (myrbetriq) (1 trial)
palmitic acid (1 trial)
Fragile X Syndrome (Phase 2)
Prostatic Neoplasms (Phase 3)
Syndrome (Phase 2)
Trials (4 total)
Trial APIs (10 total)